These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23393002)

  • 41. Characterization of adrenal autoantigens recognized by sera from patients with autoimmune polyglandular syndrome (APS) type I.
    Uibo R; Perheentupa J; Ovod V; Krohn KJ
    J Autoimmun; 1994 Jun; 7(3):399-411. PubMed ID: 7916911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis.
    Manz B; Scholz GH; Willgerodt H; Haustein UF; Nenoff P
    Eur J Dermatol; 2002; 12(3):283-6. PubMed ID: 11978574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Seric 21-hydroxilase antibodies in patients with anti-microsomal fraction antibodies. Autoimmune polyendocrine syndrome].
    Botta S; Roveto S; Rimoldi D
    Medicina (B Aires); 2007; 67(2):143-6. PubMed ID: 17593598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pregnancy complicated by autoimmune polyglandular syndrome type II: a case report.
    Gaither K; Wright R; Apuzzio JJ; Gittens L; Ganesh V
    J Matern Fetal Med; 1998; 7(3):154-6. PubMed ID: 9642614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Autoimmune polyendocrine syndrome (APS). Chief symptoms depend on involved organs].
    Kolyvanos Naumann U; Furrer J; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Jun; 94(24-25):1007-12; quiz 1013. PubMed ID: 15997717
    [No Abstract]   [Full Text] [Related]  

  • 46. Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis.
    Schumann C; Faust M; Gerharz M; Ortmann M; Schubert M; Krone W
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):302-7. PubMed ID: 15926118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of autoimmune urticaria accompanying autoimmune polyglandular syndrome type III associated with Hashimoto's disease, type 1 diabetes mellitus, and vitiligo.
    Kasznicki J; Drzewoski J
    Endokrynol Pol; 2014; 65(4):320-3. PubMed ID: 25185856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation].
    Förster G; Krummenauer F; Kühn I; Beyer J; Kahaly G
    Dtsch Med Wochenschr; 1999 Dec; 124(49):1476-81. PubMed ID: 10629665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Polyglandular autoimmune syndrome type II].
    Császár T; Patakfalvi A
    Orv Hetil; 1993 Jul; 134(29):1591-3. PubMed ID: 8336930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Autoimmune polyglandular syndromes].
    Krysiak R; Okopien B; Bołdys A
    Przegl Lek; 2008; 65(9):393-400. PubMed ID: 19140388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Screening for autoimmune polyglandular syndrome in a cohort of patients with type 1 diabetes mellitus].
    Gouveia S; Gomes L; Ribeiro C; Carrilho F
    Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):733-8. PubMed ID: 24402020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).
    Guo CJ; Leung PSC; Zhang W; Ma X; Gershwin ME
    Autoimmun Rev; 2018 Jan; 17(1):78-85. PubMed ID: 29108822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schmidt syndrome--a rare polyendocrinopathy.
    Chakrabarti D; Mallik K; Bhattacharyya AK
    J Indian Med Assoc; 2012 Jun; 110(6):406-7. PubMed ID: 23360049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurologic consequences of autoimmune polyglandular syndrome type 1.
    Berger JR; Weaver A; Greenlee J
    Neurology; 2008 Jun; 70(23):2248-51. PubMed ID: 18519874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Psycho-immuno-endocrinology of the thyroid gland].
    Šterzl I; Absolonová K; Matucha P
    Vnitr Lek; 2016; 62(9 Suppl 3):107-114. PubMed ID: 27734702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
    Amerio P; Tracanna M; De Remigis P; Betterle C; Vianale L; Marra ME; Di Rollo D; Capizzi R; Feliciani C; Tulli A
    Clin Exp Dermatol; 2006 Sep; 31(5):746-9. PubMed ID: 16803462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction.
    Betterle C; Dal Pra C; Mantero F; Zanchetta R
    Endocr Rev; 2002 Jun; 23(3):327-64. PubMed ID: 12050123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoimmune polyglandular syndrome type I. A case report.
    Cinaz P; Bideci A; Haznedaroğlu A; Ezgü FS; Ağaoğlu O; Kürşaklioğlu S
    Turk J Pediatr; 1997; 39(2):271-5. PubMed ID: 9223927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome.
    Maclaren N; Chen QY; Kukreja A; Marker J; Zhang CH; Sun ZS
    J Soc Gynecol Investig; 2001; 8(1 Suppl Proceedings):S52-4. PubMed ID: 11223374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome.
    Söderbergh A; Gustafsson J; Ekwall O; Hallgren A; Nilsson T; Kämpe O; Rorsman F; Annerén G
    Acta Paediatr; 2006 Dec; 95(12):1657-60. PubMed ID: 17129978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.